Backed by New Investors, LightSpeed Genomics Plans to Test its Detection Tech for Sequencing | GenomeWeb

After going through a restructuring phase at the end of last year in which it temporarily laid off its entire staff, LightSpeed Genomics has secured new investors and continues to develop its optical-detection technology, which it plans to integrate with a new sequencing chemistry this year, In Sequence has learned.

The startup, based in Sunnyvale, Calif., said it believes that the resulting sequencing system will provide "dramatically improved cost and speed of sequencing."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.